Chris Nave

Non-Executive Director at Osprey Medical

Dr Nave was appointed a non-executive director of the Company on 24 October 2005 and currently serves on the Audit and Risk Committee and as Chair of the Nomination and Remuneration Committee.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Osprey Medical

Osprey Medical develops and commercializes its propriety CINCOR™ System designed for the prevention of contrast induced mephropathy.


Employees

11-50

Links